Analyst Jeff Johnson from Robert W. Baird maintained a Buy rating on Insulet (PODD – Research Report) and keeping the price target at ...

Perdita, by sociologist Dylan Riley, is a beautiful attempt both to relive his marriage and to see the world through his late wife’s eyes ...

Penny’s 19th installment in the beloved Gamache series is a particularly haunting and relevant mystery novel. Yael van der Wouden’s novel, shortlisted for this year’s Booker Prize, is about ...

Read the latest London theatre reviews on the newest openings across the West End and beyond. Discover more about the latest must-see West End shows, Off-West End productions, and why you need to see ...

Insulet’s PODD robust execution to expand the Omnipod 5 platform globally is a tailwind. The company is also capitalizing on the significant growth opportunities in the Type 2 diabetes space. PODD ...

Friday marks the first day of National Diabetes Awareness Month, an opportunity to raise awareness and take action to tackle ...

ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...

WASHINGTON (Reuters) - Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a major accomplishment of the Biden administration ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

For example, users can bolus for a meal, change a pump and adjust settings. Additionally, it means Omnipod 5 users with a compatible iPhone no longer need to carry a separate controller device.

As Miller put it, "It remembers diabetes when you want to forget." "It's these automated insulin deliveries, these continuous glucose monitors, these AI artificial intelligence algorithms ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...